发明名称 Compounds for the reduction of beta-amyloid production
摘要 Compounds of formula (I), including pharmaceutically acceptable salts thereof, are set forth herein: wherein X is selected from the group of CH2, O, and NR2; m=0 or 1; R1 at each instance is selected from the group of halogen, hydroxy, amino, C1-4alkylamino, C1-4dialkylamino, haloC1-4 alkyl, CN, C1-C6 alkyl or cycloalkyl, C1-C6 alkoxy, and C2-C4 alkynyl; L is a bond, -NHCO-, -NH-, or L and Z together can be absent; Z is a C6-C10-aryl group or a 5-10 membered heterocyclic group which can be further substituted with from 0-3 substituents selected from the group of halogen, haloC1-4 alkoxy, 4-methoxyphenyl, hydroxy, amino, C1-4alkylamino, C1-4dialkylamino, haloC1-4 alkyl, CN, C1-C6 alkyl or cycloalkyl, C1-C6 alkoxy, and C2-C4 alkynyl; R2 is selected from the group of hydrogen, benzyl, C1-C6 alkyl or cycloalkyl, C1-C6 alkoxy, acetyl, and methanesulfonyl; and R3, R4 and R5 are independently selected from hydrogen or C1-4alkyl.
申请公布号 US8604024(B2) 申请公布日期 2013.12.10
申请号 US201213477143 申请日期 2012.05.22
申请人 THOMPSON, III LORIN A.;SHI JIANLIANG;WU YONG-JIN;MARCIN LAWRENCE R.;RAJAMANI RAMKUMAR;HIGGINS MENDI A.;BRISTOL-MYERS SQUIBB COMPANY 发明人 THOMPSON, III LORIN A.;SHI JIANLIANG;WU YONG-JIN;MARCIN LAWRENCE R.;RAJAMANI RAMKUMAR;HIGGINS MENDI A.
分类号 C07D279/08;C07D417/10;C07D513/04 主分类号 C07D279/08
代理机构 代理人
主权项
地址